Vaxart Slides After Reporting Delay Of Trial For Potential COVID-19 Oral Vaccine
May 03, 2021 at 16:08 PM EDT
Shares of Vaxart are under pressure on Monday after the company reported worse-than-expected first quarter losses and said that its Phase II trial of VXA-CoV2-1 is now expected to start mid-year 2021 instead of in the second quarter.
